Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blue light HAL-assisted transurethral resection vs white light resection for newly diagnosed superficial bladder cancer
2004-002760-16Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hexaminolevulinate in bladder cancer (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Tumor recurrence at one year. Started Feb 2005; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2004-002760-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002760-16.